Daré Bioscience, a clinical-stage biopharmaceutical company developing innovative products for women’s health, announced it entered into an agreement to acquire privately-held Microchips Biotech, Inc.  Daré entered into the agreement to secure Microchips’ innovative, drug delivery technology, which it intends to evaluate as a programmable contraceptive.